On-treatment serum prostate-specific antigen and overall survival in prostate cancer (STAMPEDE platform protocol): a post-hoc analysis of data from five phase 3 trialsMahaz Kayani, Carmel Pezaro, Laura Murphy et al.|The Lancet Oncology|2026Cited by 3
UK real-world data of radium-223 dichloride in metastatic prostate cancerManreet Randhawa, G. M. RACE, Amarnath Challapalli et al.|Nuclear Medicine Communications|2025Cited by 1